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The aim of the study was to establish a protocol for generation of MAP-specific T-cell lines and to use 
these lines for evaluation of a peptide vaccine. 
A protocol for culturing T-cell lines from peripheral blood of goats naturally infected with MAP was 
established. CD4+ T cells were positively selected using an anti CD4 mAb and Dynabeads. Sorted 
CD4+ cells were cultivated with purified protein derivative from MAP (PPDj) or E. coli sonicate, IL-2, 
and IL-15. After two cultivation cycles, T cells were tested for recall responses in a proliferative T-cell 
assay. T-cell line responses were in average 92 % for PPDj, and -3 % for E. coli sonicate. CD4+ T-cell 
lines stimulated with PPDj showed a 6 fold increase in IFN- γ production compared to controls. These 
results indicated that the T-cell lines were MAP-specific.  
The protocol was subsequently used to evaluate MAP-specific peptides as vaccine antigens. T-cell 
lines were now generated by cultivating CD4+ cells with peptides instead of PPDj. Initially, both 
healthy and MAP-infected goats were vaccinated with 119 peptides defined by in silico analysis. 
Cellular responses to the peptides were not detected using standard IFN- γ plasma ELISA.  However, 
testing of T-cell lines from the MAP-infected goats identified peptides that induced strong 
proliferative responses. The 23 peptides inducing the strongest responses were used in a second 
vaccination trail with healthy goat kids. Vaccinated kids developed strong IFN-γ and antibody 
responses, and these MAP-specific peptides show great potential for use in a subunit vaccine. 
Generation of T-cell lines was a valuable tool for selecting MAP vaccine antigens, and the protocol 
can also be applied for identifying vaccine candidates for other diseases. 
 
 
 
 
 
